Revolution Medicines, Inc. (RVMDW) stock
RVMDWNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as RVMD
$9.81+0.18 (+1.82%)
Close on Oct 30, 2026Market cap $41.00BP/E –Yield –
Revolution Medicines market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Revolution Medicines's market cap was $39.02B on Oct 19, 2026, against $11.00B a year earlier. Over the last 5 years it ranged from $1.26B to $44.04B, with a median of $6.32B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $39.02B | +158.3% |
| 2025 | Dec 31, 2025 | $15.11B | +105.9% |
| 2024 | Dec 31, 2024 | $7.34B | +133.7% |
| 2023 | Dec 29, 2023 | $3.14B | +50.1% |
| 2022 | Dec 30, 2022 | $2.09B | +12.8% |
| 2021 | Dec 31, 2021 | $1.85B | -29.4% |
| 2020 | Dec 31, 2020 | $2.63B | – |